Keywords: ROCHE, TRIAL DATA, TAMIFLU, DANIEL O'DAY, GOTZSCHE, GOLDACRE

Roche expands access to clinical trial data

Article | 28 February 2013

Print This

Roche has said it will increase access to its clinical trial data for third-party researchers in a bid to
boost transparency.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in